Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group studyRachelle Lanciano, Alison Calkins, Brian N Bundy, et al.The Journal of Clinical Endocrinology and Metabolism|July 26, 2022
Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 DiabetesLaura M Jacobsen, Brian N Bundy, Heba M Ismail, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology GroupMahesh A Varia, Frederick B Stehman, Brian N Bundy, et al.Lung Cancer (Amsterdam, Netherlands)|June 7, 2005
Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)Xiang Ling, Jie Yang, Dongfeng Tan, et al.Gynecologic Oncology|May 26, 2005
Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group studyGregory Sutton, Janice H Axelrod, Brian N Bundy, et al.Gynecologic Oncology|June 12, 2003
Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology GroupHenry M Keys, Brian N Bundy, Frederick B Stehman, et al.Investigational New Drugs|October 31, 2006
The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cellsTracy A Brooks, Kieran L O'Loughlin, Hans Minderman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group StudyHarry J Long, Brian N Bundy, Edward C Grendys, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2023
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyRobert F Ozols, Brian N Bundy, Benjamin E Greer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyRobert F Ozols, Brian N Bundy, Benjamin E Greer, et al.Pageof 4